World Allergy Organization-McMaster University Guidelines for Allergic Disease Prevention (GLAD-P): Probiotics

Holger J. Schünemann, Jan Brożek, Arnav Agarwal, Luigi Terracciano, Hugh A. Sampson, Motohiro Ebisawa, Susan L. Prescott, Kangmo Ahn, Juan José Yepes-Núñez, John J. Riva, Susan Waserman, Carlos A. Cuello‐García, Kirsten Beyer, Alessandro Fiocchi, Bee Wah Lee, Giorgio Walter Canonica, Ruby Pawankar, Wesley Burks, Shreyas Gandhi, Haiqi Li, Lanny J. Rosenwasser, Suleiman Al‐Hammadi, Rose Kamenwa, Michael Spigler, Andrea Vereda-Ortiz
2015-01-01

SCID:  54.1/zyfbuxej
BACKGROUND: Prevalence of allergic diseases in infants, whose parents and siblings do not have allergy, is approximately 10% and reaches 20-30% in those with an allergic first-degree relative. Intestinal microbiota may modulate immunologic and inflammatory systemic responses and, thus, influence development of sensitization and allergy. Probiotics have been reported to modulate immune responses and their supplementation has been proposed as a preventive intervention. OBJECTIVE: The World Allergy Organization (WAO) convened a guideline panel to develop evidence-based recommendations about the use of probiotics in the prevention of allergy. METHODS: We identified the most relevant clinical questions and performed a systematic review of randomized controlled trials of probiotics for the prevention of allergy. We followed the Grading of Recommendations Assessment, Development and Evaluation (GRADE) approach to develop recommendations. We searched for and reviewed the evidence about health effects, patient values and preferences, and resource use (up to November 2014). We followed the GRADE evidence-to-decision framework to develop recommendations. RESULTS: Currently available evidence does not indicate that probiotic supplementation reduces the risk of developing allergy in children. However, considering all critical outcomes in this context, the WAO guideline panel determined that there is a likely net benefit from using probiotics resulting primarily from prevention of eczema. The WAO guideline panel suggests: a) using probiotics in pregnant women at high risk for having an allergic child; b) using probiotics in women who breastfeed infants at high risk of developing allergy; and c) using probiotics in infants at high risk of developing allergy. All recommendations are conditional and supported by very low quality evidence. CONCLUSIONS: WAO recommendations about probiotic supplementation for prevention of allergy are intended to support parents, clinicians and other health care professionals in their decisions whether to use probiotics in pregnancy and during breastfeeding, and whether to give them to infants.
Publication Details
Publication Date
2015-01-01
Journal
Publisher
ISSN
Access Type
Author Information
Authors
Holger J. Schünemann
Jan Brożek
Arnav Agarwal
Luigi Terracciano
Hugh A. Sampson
Motohiro Ebisawa
Susan L. Prescott
Kangmo Ahn
Juan José Yepes-Núñez
John J. Riva
Susan Waserman
Carlos A. Cuello‐García
Kirsten Beyer
Alessandro Fiocchi
Bee Wah Lee
Giorgio Walter Canonica
Ruby Pawankar
Wesley Burks
Shreyas Gandhi
Haiqi Li
Lanny J. Rosenwasser
Suleiman Al‐Hammadi
Rose Kamenwa
Michael Spigler
Andrea Vereda-Ortiz
Explore More Research
Use the citation graph to discover related papers and expand your research horizons.
Click any node to explore
Download PDF
100%